#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholestatic pruritus Inflammatory myofibroblastic tumour Hormone-dependent prostate cancer Acute hepatic failure Vulval cancer recurrent Cluster headache Myotonia Multiple system atrophy Immune-mediated renal disorder Hepatocellular carcinoma Turner's syndrome Bile acid synthesis disorder Hepatic cirrhosis Ataxia telangiectasia Pyruvate dehydrogenase complex deficiency More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Life with Disease Toxic epidermal necrolysis – Trials in Disease Urea cycle disorder – Trials in Disease Pemphigoid – Basic Information Optic glioma – Diagnostics Combined immunodeficiency Ewing’s sarcoma metastatic – Life with Disease Glycogen storage disease type I – Life with Disease Hereditary angioedema – Diagnostics Malignant fibrous histiocytoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olorofim RIMIDUCID Prasterone Osteodex Ab-1002 Rituximab BMS-986470 VHB937 Cx-044933 Odm-208 Tobramycin Fremanezumab Allopurinol Sodium Dactinomycin LUNRESERTIB Apg777 ABY-271 Buloxibutid [68GA]GA-NOTA-AE105 HUPERZINE A More therapies…

    Learn about Your Condition

    Thymoma Mastocytosis Otitis media Deafness neurosensory Chondrosarcoma Prinzmetal angina Coeliac disease Osteonecrosis of jaw Bacterial prostatitis Small fibre neuropathy Cardiomyopathy Gestational diabetes Restless legs syndrome Synovial sarcoma recurrent Osteosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Behcet’s syndrome

  • A study to evaluate the long-term safety of apremilast in children with oral ulcers from Behçet’s disease or juvenile psoriatic arthritis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Apremilast
    Greece Italy Spain

  • Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Tocilizumab
    France

  • Study on Steroid and Rivaroxaban Treatment for Deep Vein Thrombosis in Behçet’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    Investigated Drugs:
    • Rivaroxaban
    France

  • Study on Apremilast for Treating Oral Ulcers in Children with Behçet’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Apremilast
    France Greece Italy Spain

  • Study on Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Behcet’s syndrome
    • Dermatomyositis
    Investigated Drugs:
    • Filgotinib
    The Netherlands

  • Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Behcet’s syndrome
    • Immunoglobulin G4 related disease
    Investigated Drugs:
    • Filgotinib
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!